Artivion (AORT) CEO sells 17,580 shares at $44.619 for taxes
Artivion (AORT) reported an insider transaction by President & CEO James P. Mackin.
Rhea-AI Filing Summary
Artivion (AORT) reported an insider transaction by President & CEO James P. Mackin.
On 11/10/2025, 17,580 shares of common stock were sold at $44.619 in a sell-to-cover tied to RSU vesting to satisfy tax withholding; the filing states this was not a discretionary trade.
After the transaction, he directly beneficially owned 835,203 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 17,580 shares
Net Sell
1 txn
Insider
Mackin James P
Role
President & CEO
Sold
17,580 shs ($784K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 17,580 | $44.619 | $784K |
Holdings After Transaction:
Common Stock — 835,203 shares (Direct)
Footnotes (1)
- F1. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Artivion (AORT) disclose in this Form 4?
A sale of 17,580 common shares by CEO James P. Mackin at $44.619 on 11/10/2025.
What price and date were involved in the AORT insider sale?
The sale occurred on 11/10/2025 at $44.619 per share.
What is the role of the reporting person at Artivion (AORT)?
James P. Mackin is the President & CEO.
Was this an open-market discretionary sale?
No. The filing states it was a sell-to-cover for tax withholding and not a discretionary transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.